Production of hydrogen peroxide by peripheral blood monocytes and specific macrophages during experimental infection with Trypanosoma cruzi in vivo

Cell Biology International

Volumn 27, Issue 10, 2003, Pages 853-861

  Melo, Rossana C N ^a,b   Fabrino, Daniela L ^a   D'Ávila, Heloisa ^a   Teixeira, Henrique C ^a   Ferreira, Ana Paula ^a  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Chagas' disease; Electron microscopy; Hydrogen peroxide; Monocytes macrophages; Myocarditis; Trypanosoma cruzi

Indexed keywords

HYDROGEN PEROXIDE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL SIZE; CELL STRUCTURE; CELL ULTRASTRUCTURE; CONTROLLED STUDY; EXPERIMENTAL INFECTION; FEMALE; HEART MUSCLE CELL; HOST PARASITE INTERACTION; HOST RESISTANCE; INFECTION RESISTANCE; INFLAMMATORY CELL; MACROPHAGE; MONOCYTE; MYOCARDITIS; NONHUMAN; PERITONEUM MACROPHAGE; PROTOZOAL INFECTION; RAT; RESPIRATORY BURST; SPLEEN CELL; TRYPANOSOMA CRUZI; TRYPANOSOMIASIS;

TRYPANOSOMA; TRYPANOSOMA CRUZI;

EID: 0141853754     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1065-6995(03)00173-2     Document Type: Article

References (40)

1. Abrahamsohn I.A., Coffman R.L. Trypanosoma cruzi: IL-10, TNF, IFN-gamma, and IL-12 regulate innate and acquired immunity to infection. Exp Parasitol. 84:(2):1996;231-244.
2. Abreu M.A., Baroza L.G.V., Rossi M.A. Toluidine Blue-Basic Fuchisin stain for glycolmetacrylate embedded tissue. J Histotechnol. 16:(2):1993;139-140.
3. Andrade Z.A. Pathogenesis of Chagas' disease. Res Immunol. 142:(2):1991;126-151.
4. Anosa V.O., Loganhenfrey L.L., Wells C.W. The haematology of Trypanosoma cruzi congolense infection in cattle. 2. Macrophage structure and function in the bone marrow of Boran cattle. Comp Haemat Int. 7:(1):1997;23-29.
5. Antunez M.I., Cardoni R.L. IL-12 and IFN-gamma production, and NK cell activity, in acute and chronic experimental Trypanosoma cruzi infections. Immunol Lett. 71:(2):2000;103-109.
6. Brener Z., Gazzinelli R.T. Immunological control of Trypanosoma cruzi infection and pathogenesis of Chagas' disease. Int Arch Allergy Immunol. 114:1997;103-110.
7. Borges M.M., Vassao R., Andrade S.G., Pereira C.A., Kloetzel J.K. Interferon-Gama levels during the course of Trypanosoma cruzi infection of Calomys callosus (Rodentia-Cricetidae) and Swiss mice. Parasitol Res. 81:1995;498-504.
8. Celentano A.M., González-Cappa S.M. Induction of macrophage activation and opsoning antibodies by Trypanosoma cruzi subpopulations. Parasite Immunol. 14:1992;155-167.
9. El Shewemi S., Alshammary F., Alzamel F., Soliman R. Ultrastructure of resting and rh-GMCSF-treated human macrophages derived from blood monocytes. J Electron Microsc. 45:(5):1996;388-394.
10. Hanson W.L., Roberson E.L. Density of parasites in various organs and the relation to numbers of trypomastigotes in blood during acute infections of Trypanosoma cruzi in mice. J Protozol. 21:(4):1974;512-517.
11. Jaramillo M., Olivier M. Hydrogen peroxide induces murine macrophage chemokine gene transcription via extracellular signal-regulated kinase- and cyclic adenosine 5′- Monophosphate (cAMP)-dependent pathways: involvement of NF-κB, activator protein 1, and cAMP response element binding protein. J Immunol. 169:2002;7026-7038.
12. Karnovsky M.J. A formaldehyde-glutaraldehyde fixative of high osmolality for use in electron microscopy. J Cell Biol. 27:1965;137A-138A.
13. Mccabe R.E., Mullins B.T. Failure of Trypanosoma cruzi to trigger the respiratory burst of activated macrophages. J Immunol. 144:1990;2384-2388.
14. Melo R.C.N. Depletion of immune effector cells induces myocardial damage in the acute experimental Trypanosoma cruzi infection: ultrastructural study in rats. Tissue Cell. 31:(3):1999;281-290.
15. Melo R.C.N., Machado C.R.S. Depletion of radiosensitive leukocytes exacerbates the heart sympathetic denervation and parasitism in experimental Chagas' disease in rats. J Neuroimmunol. 84:1998;151-157.
16. Melo R.C.N., Machado C.R.S. Trypanosoma cruzi: peripheral blood monocytes and heart macrophages in the resistance to acute experimental infection in rats. Exp Parasitol. 97:2001;15-23.
17. Melo R.C.N., D'Avila H., Fabrino D.L., Almeida P.E., Bozza P.T. Macrophage lipid body induction by Chagas' disease in vivo: putative intracellular domains for eicosanoid formation during infection. Tissue Cell. 35:(1):2003;59-67.
18. Mytar B., Siedlar M., Woloszyn M., Ruggiero I., Pryjma J., Zembala M. Induction of reactive oxygen intermediates in human monocytes by tumour cells and their role in spontaneous monocyte cytotoxicity. Br J Cancer. 79:(5-6):1999;737-743.
19. Nathan C.F. Secretion of oxygen intermediates: role in effector functions of activated macrophages. Fed Proc. 41:1982;2206-2211.
20. Nathan C., Nogueira N., Juanghanich C., Ellis J., Cohn Z. Activation of macrophages in vivo and in vitro. J Exp Med. 149:1979;1056-1068.
21. Nogueira N., Cohn Z.A. Trypanosoma cruzi: in vitro induction of macrophage microbicidal activity. J Exp Med. 148:1978;288-300.
22. Petray P., Castanosvelez E., Grinstein S., Orn A., Rottenberg M.E. Role of nitric-oxide in resistance and histopathology during experimental infection with Trypanosoma cruzi. Immunol Lett. 47:(1-2):1995;121-126.
23. Pick E., Mizel D. Rapid microssays for a the measurement of superoxide and hydrogen peroxide production by macrophages in culture using na automatic enzime immunoassay reader. J Immunol Methods. 46:1981;211-226.
24. Reed S.G., Nathan C.F., Pihl D.L., Rodricks P., Shanebeck K., Conlon P.J., et al. Recombinant granulocyt/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon γ J Exp Med. 166:1987;1734-1746.
25. Reth M. Hydrogen peroxide as second messenger in lymphocyte activation. 2002. Nat Immunol. 3:(12):2002;1129-1134.
26. Revelli S., Didoli G., Roggero E., Moreno H., Bernabo J., Wietzerbin J., et al. Macrophage activity, IL-6 levels, antibody response and heart histology in rats undergoing an attenuated Trypanosoma cruzi acute infection upon treatment with recombinant interferon gamma. Cyt Cell Mol Ther. 4:(3):1998;153-159.
27. Rodrigues M.M., Ribeirão M., Boscardin S.B. CD4 Th1 but not Th2 clones efficiently activate macrophages to eliminate Trypanosoma cruzi through a nitric oxide dependent mechanism. Immunol Lett. 73:(1):2000;43-50.
28. Ropert C., Ferreira L.R.P., Campos M.A.S., Procopio D.O., Travassos L.R., Ferguson M.A.J., et al. Macrophage signaling by glycosylphatylinositol-anchored mucin-like glycoproteins derived from Trypanosoma cruzi trypomastigotes. Microbes Infect. 4:2002;1015-1025.
29. Russo M., Starobinas N., Ribeiro dos Santos R., Minoprio P.O., Hontebeyre-Joskowicz M. Susceptible mice present higher macrophage activation than resistant mice during infection with myotropic strains of Trypanosoma cruzi. Parasite Immunol. 11:1989;385-395.
30. Saeftel M., Fleischer B., Hoerauf A. Stage-dependent role of nitric oxide in control of Trypanosoma cruzi infection. Infect Immun. 69:(4):2002;2252-2259.
31. Silva L.H.P., Nussenszweig V. Sobre uma cepa de Trypanosoma cruzi altamente virulenta para o camundongo branco. Fol Clin Biol. 20:1953;191-208.
32. Silva J.S., Vespa G.N.R., Cardoso M.A.G., Aliberti J.C.S., Cunha F.Q. Tumor-Necrosis-Factor-Alpha mediates resistance to Trypanosoma cruzi infection in mice by inducing nitric-oxide production in infected gamma-interferon-activated macrophages. Infect Immun. 63:(12):1995;4862-4867.
33. Sun J., Tarleton R.L. Predominance of CD8+ T lymphocytes in the inflammatory lesions of mice with acute Trypanosoma cruzi infection. Am J Trop Med Hyg. 48:1993;161-169.
34. Takemura T., Rom W.N., Ferrans V.J., Crystal R.G. Morphologic characterization of alveolar macrophages from subjects with occupational exposure to inorganic particles. Amn Rev Resp Dis. 140:1989;1674-1685.
35. Tanaka Y., Tanowitz H., Bloom B.R. Growth of Trypanosoma cruzi in a cloned macrophage cell line and in a variant defective in oxygen metabolism. Infect Immun. 41:(3):1983;1322-1331.
36. Tanowitz H.B., Kirchhoff L.V., Simon D., Morris S.A., Weiss L.M., Wittner M. Chagas' disease. Clin Microbiol Rev. 5:(4):1992;400-419.
37. Turpin J.A., Lopez-Berestein G. Differentiation, maturation, and activation of monocytes and macrophages: functional activity is controlled by a continuum of maturation. Lopez-Berestein G., Klostergaard J. Mononuclear phagocytes in cell biology. 1993;71-99 CRC Press, Boca Raton (FL).
38. Van Voorhis W. Coculture of human peripheral blood mononuclear cells with Trypanosoma cruzi leads to proliferation of lymphocytes and cytokine production. J Immunol. 148:(1):1992;239-248.
39. Vespa G.N.R., Cunha F.Q., Silva J.S. Nitric oxide is involved in control of Trypanosoma cruzi-induced parasitemia and directly kills the parasite in vitro. Infect Immun. 62:(11):1994;5177-5182.
40. Villalta F., Kierszenbaum F. Role of inflammatory cells in Chagas' disease. II. Interactions of mouse macrophages and human monocytes with intracellular forms of Trypanosoma cruzi: uptake and mechanism of destruction. J Immunol. 133:(6):1984;3338-3343.